Odds ratios of cardiovascular deaths after the diagnosis of primary DTC-2 developed in survivors of nonthyroidal malignancy in case-crossover analysisa: a population-based study in the United States, 1975-2020
| . | Cardiovascular deaths, n (%) . | Matched cases, n (%) . | OR (95% CI)b . | ||
|---|---|---|---|---|---|
| Control period . | Hazard period . | Control period . | Hazard period . | ||
| Overall | 94 (81.7) | 21 (18.3) | 2380 (89.9) | 266 (10.1) | 2.00 (1.22-3.26) |
| By attained age | |||||
| 30-74 years | 34 (75.6) | 11 (24.4) | 1723 (90.8) | 174 (9.2) | 3.20 (1.59-6.44) |
| ≥75 years | 60 (85.7) | 10 (14.3) | 657 (87.7) | 92 (12.3) | 1.19 (0.59-2.41) |
| . | Cardiovascular deaths, n (%) . | Matched cases, n (%) . | OR (95% CI)b . | ||
|---|---|---|---|---|---|
| Control period . | Hazard period . | Control period . | Hazard period . | ||
| Overall | 94 (81.7) | 21 (18.3) | 2380 (89.9) | 266 (10.1) | 2.00 (1.22-3.26) |
| By attained age | |||||
| 30-74 years | 34 (75.6) | 11 (24.4) | 1723 (90.8) | 174 (9.2) | 3.20 (1.59-6.44) |
| ≥75 years | 60 (85.7) | 10 (14.3) | 657 (87.7) | 92 (12.3) | 1.19 (0.59-2.41) |
Abbreviations: CI, confidence interval; DTC-2, differentiated thyroid cancer as a second malignancy; n, number of deaths; OR, odds ratio.
aThis analysis included all second primary differentiated thyroid cancer patients. The hazard period was defined as the 1 month (30 days) preceding cardiovascular death and the control periods as the 17 1-month periods preceding the hazard period.
bThe OR is the odds a case would have fallen within the hazard period in the cardiovascular deaths group vs that in the matched cases group.
Odds ratios of cardiovascular deaths after the diagnosis of primary DTC-2 developed in survivors of nonthyroidal malignancy in case-crossover analysisa: a population-based study in the United States, 1975-2020
| . | Cardiovascular deaths, n (%) . | Matched cases, n (%) . | OR (95% CI)b . | ||
|---|---|---|---|---|---|
| Control period . | Hazard period . | Control period . | Hazard period . | ||
| Overall | 94 (81.7) | 21 (18.3) | 2380 (89.9) | 266 (10.1) | 2.00 (1.22-3.26) |
| By attained age | |||||
| 30-74 years | 34 (75.6) | 11 (24.4) | 1723 (90.8) | 174 (9.2) | 3.20 (1.59-6.44) |
| ≥75 years | 60 (85.7) | 10 (14.3) | 657 (87.7) | 92 (12.3) | 1.19 (0.59-2.41) |
| . | Cardiovascular deaths, n (%) . | Matched cases, n (%) . | OR (95% CI)b . | ||
|---|---|---|---|---|---|
| Control period . | Hazard period . | Control period . | Hazard period . | ||
| Overall | 94 (81.7) | 21 (18.3) | 2380 (89.9) | 266 (10.1) | 2.00 (1.22-3.26) |
| By attained age | |||||
| 30-74 years | 34 (75.6) | 11 (24.4) | 1723 (90.8) | 174 (9.2) | 3.20 (1.59-6.44) |
| ≥75 years | 60 (85.7) | 10 (14.3) | 657 (87.7) | 92 (12.3) | 1.19 (0.59-2.41) |
Abbreviations: CI, confidence interval; DTC-2, differentiated thyroid cancer as a second malignancy; n, number of deaths; OR, odds ratio.
aThis analysis included all second primary differentiated thyroid cancer patients. The hazard period was defined as the 1 month (30 days) preceding cardiovascular death and the control periods as the 17 1-month periods preceding the hazard period.
bThe OR is the odds a case would have fallen within the hazard period in the cardiovascular deaths group vs that in the matched cases group.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
